To assess how payer costs for allogeneic BMT relate to patient characteristics and clinical complications, a retrospective cohort study of 402 persons undergoing allogeneic BMT between 1980 and 1987 at a university-based BMT center was designed to determine total inpatient payer costs, including hospital and physician costs, and number of days hospitalized during the first 180 days following BMT.
The average total inpatient payer cost (in 1990 dollars) during the first 180 days following BMT was $208 410.
Inflation-adjusted inpatient payer costs increased from $227 806 in 1980 to $308545 in 1983, and then decreased to $156163 by 1987.
Mots-clés Pascal : Economie santé, Traitement, Homme, Homogreffe, Moelle osseuse
Mots-clés Pascal anglais : Health economy, Treatment, Human, Homograft, Bone marrow
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0592073
Code Inist : 002B27B16B. Création : 199406.